An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis.

Xiayu Rao(The University of Texas MD Anderson Cancer Center), Xin Lin(Hainan Medical University), Xuelin Huang(The University of Texas MD Anderson Cancer Center), Zhicheng Zhou(The University of Texas MD Anderson Cancer Center)
PubMed
August 1, 2013
Cited by 1,600

Related Papers

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia
|Blood|2006|691
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study
|The Lancet Oncology|2016|405
Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia
|JAMA Oncology|2020|380
DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes
|Journal of Clinical Oncology|2009|359
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
|Clinical Cancer Research|2015|355